255 related articles for article (PubMed ID: 27852288)
1. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms and clinical significance of PDCD4 in colorectal cancer.
Long J; Yin Y; Guo H; Li S; Sun Y; Zeng C; Zhu W
Gene; 2019 Jan; 680():59-64. PubMed ID: 30243936
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.
Ma X; Bai J; Xie G; Liu Y; Shuai X; Tao K
PLoS One; 2017; 12(7):e0180173. PubMed ID: 28742860
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death 4 mechanism of action: The model to be updated?
Vikhreva PN; Kalinichenko SV; Korobko IV
Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
[TBL] [Abstract][Full Text] [Related]
7. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
8. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
9. mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells.
Vikhreva PN; Shepelev MV; Korobko IV
Biochim Biophys Acta; 2014 Jan; 1839(1):43-9. PubMed ID: 24334141
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection.
Zhang J; Ma L; Shi D; Zhang Z; Yao C; Zhao X; Xu Q; Wen P; He L
J Cell Biochem; 2018 Jun; 119(6):4783-4791. PubMed ID: 29331036
[TBL] [Abstract][Full Text] [Related]
11. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
[TBL] [Abstract][Full Text] [Related]
12. p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysis.
Fang F; Pan J; Li YP; Li G; Xu LX; Su GH; Li ZH; Feng X; Wang J
Oncotarget; 2016 May; 7(19):27422-9. PubMed ID: 27027431
[TBL] [Abstract][Full Text] [Related]
13. Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.
Wei NA; Liu SS; Leung TH; Tam KF; Liao XY; Cheung AN; Chan KK; Ngan HY
Mol Cancer; 2009 Sep; 8():70. PubMed ID: 19728867
[TBL] [Abstract][Full Text] [Related]
14. [Pdcd4 tumor suppressor: properties, functions, and their application to oncology].
Vikhreva PN; Shepelev MV; Korobko EV; Korobko IV
Mol Gen Mikrobiol Virusol; 2010; (2):3-11. PubMed ID: 20545042
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
16. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
Sun Z; Li S; Kaufmann AM; Albers AE
Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma.
Qi C; Shao Y; Li N; Zhang C; Zhao M; Gao F
Med Oncol; 2013 Mar; 30(1):491. PubMed ID: 23389919
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression.
Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D
Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005
[TBL] [Abstract][Full Text] [Related]
19. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.
Lankat-Buttgereit B; Göke R
Biol Cell; 2009 Jun; 101(6):309-17. PubMed ID: 19356152
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
Zhang P; Hu P; Shen H; Yu J; Liu Q; Du J
Eur J Clin Invest; 2014 Nov; 44(11):1072-94. PubMed ID: 25257753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]